GlassScriptPhysician profile
Tarrayah Latonya Brooks
NPI 1275290736
$449.11
in general payments reported to CMS, 2019-2025
8 companies · $54.85 in 2025
The $54.85 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $50.02 · 2023: $31.05 · 2024: $313 · 2025: $54.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $148.41 | 2024 | Impella |
| Glaxosmithkline, LLC. | $125.00 | 2024 | Arexvy |
| Boston Scientific Corporation | $50.02 | 2022 | |
| Itamar Medical INC | $37.38 | 2024-2025 | Watchpatone |
| Medline Industries LP | $31.05 | 2023 | |
| Recor Medical INC | $24.36 | 2025 | Paradise Ultrasound Renal Denervation System |
| Shield Therapeutics INC | $18.27 | 2024 | |
| Lilly USA, LLC | $14.62 | 2025 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarrayah Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.